Michael Recht/LinkedIn
Nov 26, 2025, 14:52
WFH Committee Member Highlight: Michael Recht on the Effectiveness of Octocog Alfa in Haemophilia A
World Federation of Hemophilia (WFH) shared on LinkedIn:
” Real-world data tell a powerful story.
In a recent study Octocog Alfa (BAY 81-8973) has shown effectiveness for people with hemophilia A, including under-represented groups, in the ATHN dataset.”
WFH has shared a committee member highlight from Michael Recht.
Read the full article here.
Article: Effectiveness of Octocog Alfa (BAY 81-8973) to Treat People With Haemophilia A Enrolled in the ATHNdataset, Including Under-Represented Subgroups
Authors: Martin Chandler, Thomas Moulton, Lena Charafi, Jessica Charlet, Michael Recht
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 12, 2026, 15:54Ralf Illing: Proud to Contribute My Patient Voice to OCEANIC-STROKE Research
-
Apr 12, 2026, 15:38Hugo Antonio Romo Rubio: ASH ISTH 2026 Guidelines on Prophylactic Anticoagulation In Pediatrics
-
Apr 12, 2026, 15:26Melissa Lewellyn: The DVT and PE Awareness Resolution from NBCA Is Now Live
-
Apr 12, 2026, 14:58Akram Shibani: HI-PEITHO Trial Reminds Us Why Composite Endpoints Deserve Careful Scrutiny
-
Apr 12, 2026, 14:493 Days, 14 Leaders, 1 Mission at The 13th EHC Youth Leadership Workshop
-
Apr 12, 2026, 14:27Moustafa Abdou: Paroxysmal Nocturnal Hemoglobinuria From a Rare Disease to a Treatable Condition
-
Apr 12, 2026, 14:18Jean Jacques Kiladjian: Grateful to the MSH for the invitation to ‘Highlights of ASH’ in Asia-Pacific 2026
-
Apr 12, 2026, 14:15Paritosh Garg: A fibrotic marrow is not always PMF
-
Apr 12, 2026, 14:13Scott Woller: ACC/AHA Guidelines and the Role of Pulmonary Embolism Response Teams